Joe E. Kiani Sells 4,464 Shares of Masimo Corp. (MASI) Stock
Masimo Corp. (NASDAQ:MASI) CEO Joe E. Kiani sold 4,464 shares of the firm’s stock in a transaction on Tuesday, September 27th. The stock was sold at an average price of $60.01, for a total transaction of $267,884.64. Following the completion of the sale, the chief executive officer now owns 123,705 shares of the company’s stock, valued at $7,423,537.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Masimo Corp. (NASDAQ:MASI) opened at 60.00 on Tuesday. Masimo Corp. has a 1-year low of $33.03 and a 1-year high of $60.52. The company has a market capitalization of $2.96 billion, a price-to-earnings ratio of 31.46 and a beta of 0.70. The firm has a 50 day moving average of $58.98 and a 200-day moving average of $51.07.
Masimo Corp. (NASDAQ:MASI) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported $0.57 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.41 by $0.16. The firm earned $172.64 million during the quarter, compared to analyst estimates of $166.02 million. Masimo Corp. had a net margin of 15.40% and a return on equity of 29.07%. The business’s quarterly revenue was up 10.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.36 EPS. On average, equities research analysts anticipate that Masimo Corp. will post $2.02 earnings per share for the current fiscal year.
Several large investors have recently made changes to their positions in MASI. Nomura Holdings Inc. acquired a new stake in shares of Masimo Corp. during the second quarter worth $286,000. Mason Street Advisors LLC acquired a new stake in shares of Masimo Corp. during the second quarter worth $453,000. Schwab Charles Investment Management Inc. raised its stake in Masimo Corp. by 1.9% in the second quarter. Schwab Charles Investment Management Inc. now owns 194,923 shares of the company’s stock worth $10,237,000 after buying an additional 3,586 shares in the last quarter. Hillsdale Investment Management Inc. raised its stake in Masimo Corp. by 16.0% in the second quarter. Hillsdale Investment Management Inc. now owns 10,900 shares of the company’s stock worth $572,000 after buying an additional 1,500 shares in the last quarter. Finally, Amalgamated Bank purchased a new stake in Masimo Corp. during the second quarter worth approximately $276,000. Hedge funds and other institutional investors own 79.88% of the company’s stock.
MASI has been the subject of a number of research reports. Wedbush restated an “outperform” rating and issued a $63.00 price target (up from $60.00) on shares of Masimo Corp. in a report on Thursday, August 4th. Piper Jaffray Cos. restated an “overweight” rating and issued a $55.00 price target (up from $52.00) on shares of Masimo Corp. in a report on Friday, August 5th. Finally, BTIG Research restated a “hold” rating on shares of Masimo Corp. in a report on Friday, August 5th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $52.60.
Masimo Corp. Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.
Receive News & Ratings for Masimo Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corp. and related companies with MarketBeat.com's FREE daily email newsletter.